Plus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Plus Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $-0.37 | $-0.56 | 33.9 % |
Jun 2024 | 2024-08-14 | $-0.71 | $-0.53 | -34.0 % |
Mar 2024 | 2024-05-15 | $-0.75 | $-1.09 | 31.2 % |
Dec 2023 | 2024-03-05 | $-0.70 | $-1.07 | 34.6 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-14 | $1.46M | $1.14M | 27.7 % |
Jun 2024 | 2024-08-14 | $1.28M | $1.67M | -23.4 % |
Mar 2024 | 2024-05-15 | $1.68M | $1.69M | -0.77 % |
Dec 2023 | 2024-03-05 | $1.31M | $1.06M | 23.9 % |
Plus Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.
Plus Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.37, which beat the estimate of $-0.56.
Plus Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.